MIRA PHARMACEUTICALS INC (MIRA) Stock Income Statement
NASDAQ:MIRA - Nasdaq - US60458C1045 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 8.06M | 8.02M | 8.53M | 7.05M | 2.15M | |||
| Research and Development | 2.86M | 3.31M | 1.57M | 2.35M | 684.50K | |||
| Selling, General, and Administrative Expenses | 5.20M | 4.71M | 6.95M | 4.70M | 1.47M | |||
| Operating Income | -8.06M | -8.02M | -8.53M | -7.05M | -2.15M | |||
| Interest Income/Expense | 136.70K | 165.70K | -3.46M | -10.30K | -24.40K | |||
| Income Before Taxes | -7.92M | -7.85M | -11.98M | -7.06M | -2.18M | |||
| Net Income | -7.92M | -7.85M | -11.98M | -7.06M | -2.18M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.50 | -0.51 | -0.81 | -0.48 | -0.15 | |||
| Non GAAP EPS | -0.52 | -0.53 | N/A | N/A | N/A | |||
| Statistics | ||||||||
All data in USD